National Institute on Drug Abuse; Notice of Closed Meeting, 14258 [E8-5087]
Download as PDF
<![CDATA[
14258
Federal Register / Vol. 73, No. 52 / Monday, March 17, 2008 / Notices
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Fax: 202–395–6974,
Attn: Desk Officer for the
Administration for Children and
Families.
Dated: March 6, 2008.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. E8–5063 Filed 3–14–08; 8:45 am]
BILLING CODE 4184–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
pwalker on PROD1PC71 with NOTICES
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel A
Market Technology Plan for Disseminating
Workplace Drug Prevention Programs.
Date: March 25, 2008.
Time: 9:30 a.m. to 4 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, lf33c.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS).
Dated: March 7, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–5087 Filed 3–14–08; 8:45 am]
BILLING CODE 4140–01–M
VerDate Aug<31>2005
16:19 Mar 14, 2008
Jkt 214001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel
Multi-Ethnic Study of Atherosclerosis
(MESA)-Coordinating Center-HC–08–10.
Date: April 11, 2008.
Time: 8 a.m. to 10:30 a.m.
Agenda: To review and evaluate contract
proposals.
Place: Courtyard by Marriott Crystal City,
2899 Jefferson Davis Highway, Arlington, VA
22202.
Contact Person: Mark Roltsch, PhD,
Scientific Review Administrator, Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7192, Bethesda, MD 20892–7924, 301–435–
0287, roltschm@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel
Multi-Ethnic Study of Atherosclerosis
(MESA)-Field Center-HC–08–11.
Date: April 11, 2008.
Time: 10:45 a.m. to 12:45 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Courtyard by Marriott Crystal City,
2899 Jefferson Davis Highway, Arlington, VA
22202.
Contact Person: Mark Roltsch, PhD,
Scientific Review Administrator, Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7192, Bethesda, MD 20892–7924, 301–435–
0287, roltschm@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel
Multi-Ethnic Study of Atherosclerosis
(MESA)-Laboratory Center-HC–08–12.
Date: April 11, 2008.
Time: 1 p.m. to 2:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Courtyard by Marriott Crystal City,
2899 Jefferson Davis Highway, Arlington, VA
22202.
Contact Person: Mark Roltsch, PhD,
Scientific Review Administrator, Review
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7192, Bethesda, MD 20892–7924, 301–435–
0287, roltschm@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel
Multi-Ethnic Study of Atherosclerosis
(MESA)-MRI Reading Center-HC–08–13.
Date: April 11, 2008.
Time: 2:45 p.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Courtyard by Marriott Crystal City,
2899 Jefferson Davis Highway, Arlington, VA
22202.
Contact Person: Mark Roltsch, PhD,
Scientific Review Administrator, Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7192, Bethesda, MD 20892–7924, 301–435–
0287, roltschm@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: March 7, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–5079 Filed 3–14–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel Pathogenesis of Francisella
Tularensis.
Date: April 9, 2008.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\17MRN1.SGM
17MRN1
]]>Agencies
[Federal Register Volume 73, Number 52 (Monday, March 17, 2008)]
[Notices]
[Page 14258]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-5087]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel A Market Technology Plan for Disseminating Workplace
Drug Prevention Programs.
Date: March 25, 2008.
Time: 9:30 a.m. to 4 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6101 Executive Boulevard,
Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439, lf33c.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS).
Dated: March 7, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-5087 Filed 3-14-08; 8:45 am]
BILLING CODE 4140-01-M
